VeriMomIst sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) in der Schwangerschaft sicher?
No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
Related ingredients
Frequently asked questions
- Ist sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) in der Schwangerschaft sicher?
- No harmonised CLP classification, SCCS or CIR reproductive safety assessments, or peer‑reviewed reproductive/toxicity studies identified for the named peptides. These are peptide/protein actives (high molecular weight, proteolytically degradable) with expected minimal dermal systemic bioavailability when used topically, and no evidence of teratogenicity or endocrine activity was found in available sources (ECHA Annex VI; PubMed; CosIng; PubChem).
- Ist sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) während des Stillens sicher?
- No data indicating reproductive or lactation hazard, no harmonised classifications, and no mechanistic evidence for transfer into breast milk. Topically applied peptides are expected to be degraded and have negligible systemic exposure; no studies suggest transfer to breast milk or effects on nursing infants (sources searched: ECHA Annex VI, PubMed, CosIng, PubChem).
- Ist sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) sicher für Babyhaut?
- No toxicity or developmental data specific to infants found. Adult hazard/mechanism assessments are absent. Although dermal absorption of intact peptides is expected to be very low, infant (0–3 yr) skin has higher surface-area-to-weight and immature barrier function, so exposure score is increased by +1 to reflect potentially higher but still likely low absorption; no evidence of infant-specific adverse effects was identified (sources: PubMed, CosIng, ECHA Annex VI, PubChem).
- Wie bewertet VeriMom sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5)?
- VeriMom bewertet sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5)?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu sr-(tetrapeptide-74 hexapeptide-40 expression vector pmbp-parallel 1 polypeptide-1 spider polypeptide-1 spider polypeptide-5) basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.